Tags » BRIC

AstraZeneca’s Crestor® Patent is Invalidated by the Brazilian Federal Courts

On June 5, 2015, the 13th Federal District Court of Rio de Janeiro invalidated Astrazeneca’s patent BR PI0003364-2 covering Crestor® (rosuvastatin). The Judge, the Honorable Marcia Nunes Barros, agreed with the arguments submitted by the Brazilian Patent Office and National Sanitary Vigilance Agency (ANVISA) that the patent was obvious over the prior art. 414 more words

Brazil

Why Bramley, my local town, is fast becoming Leeds’ answer to the BRICs.

If you don’t know what a BRIC is or specifically who they are then go here first.

Great, let’s begin.

Recently Jeremy Clarkson tweeted about Leeds and it’s development since not returning to the city for a while. 728 more words

Leeds

13th Federal District Court of Rio de Janeiro Holds that ANVISA Can Examine Patentability Requirements of Patent Applications Claiming Pharmaceutical Inventions

One of the most contentious issues in the Brazilian pharmaceutical landscape is role of National Sanitary Vigilance Agency (ANVISA) during the prior approval/consent analysis of patent applications claiming pharmaceutical inventions. 492 more words

Brazil

Brazil economy still faltering, with GDP contraction on par with Russia's

Kenneth Rapoza – Forbes, 6/19/2015

Brazil’s economy is grinding to the bottom. But the bottom doesn’t appear to have been hit just yet.

The monthly GDP proxy at the Central Bank of Brazil, known as the IBC-Br index, surprised on the downside on Friday by falling 0.84% in April. 84 more words

Nation, Politics & Government

GREECE IS (JUST) ANOTHER VICTIM OF WASHINGTON’S EMPIRE.

Paul Craig Roberts’ address to the Conference on the European/Russian Crisis, Delphi, Greece, June 20-21, 2015.

The United States has pursued empire since early in its history, but it was the Soviet collapse in 1991 that enabled Washington to see the entire world as its oyster. 3,296 more words

US Wars

ETFalpha reblogged this on EMerging Equity and commented:

The statements, views, and opinions expressed in this article are solely those of the author and do not necessarily represent those of EMerging Equity.

Presentations from 6/14 BRIC Panel at BIO Now Available

Did you miss the BRIC panel “Strategies for Successfully Mastering the Different Challenges of the IP Systems in the BRIC Countries and U.S. in the Pharmaceutical and Life Sciences Sectors,” presented in conjunction with the 2015 BIO International Convention? 16 more words

Ariosa Diagnostics, Inc. v. Sequenom, Inc. – Another Diagnostic Patent Meets its End

On Friday, June 12, 2015, the Federal Circuit issued its decision in Ariosa Diagnostics, Inc. v. Sequenom, Inc. (Fed. Cir. 2015) finding that the claims of U.S. 1,634 more words

Lisa Mueller